NuVasive Announces First Quarter 2023 Financial Results

–Continued above-market worldwide net sales growth of 5.8% as reported and 7.7% on a constant currency basis–
–U.S. cervical delivers sixth consecutive quarter of greater than 20% growth, driven by C360 and the Simplify Cervical Disc–

Read more at prnewswire.com